Advertisement
Screener

BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Material Contracts, 2022

BRAINSTORM CELL THERAPEUTICS INC. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2022-09-22: Form 8-K; Exhibit 10.1; Description Amendment No. 2 to Offer Letter Agreement dated September 18, 2022 between Brainstorm Cell Therapeutics Inc. and Dr. Stacy Lindborg..
  • 2022-03-28: Form 10-K; Exhibit 10.54; Description Brainstorm Cell Therapeutics Inc. Fourth Amendment to the Second Amended and Restated Director Compensation Plan..
FiledFormExhibitDescription
2022-09-228-K10.1Amendment No. 2 to Offer Letter Agreement dated September 18, 2022 between Brainstorm Cell Therapeutics Inc. and Dr. Stacy Lindborg.
2022-03-2810-K10.54Brainstorm Cell Therapeutics Inc. Fourth Amendment to the Second Amended and Restated Director Compensation Plan.

Similar stocks

Stock NameCountryMarket CapPE Ratio
INTENSITY THERAPEUTICS, INC. (INTS)United States$0.013B-1.08
Pluri Inc. (PLUR)$0.014B
IN8BIO, INC. (INAB)United States$0.012B-0.76
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
Passage BIO, Inc. (PASG)United States$0.015B-0.43
DYADIC INTERNATIONAL INC (DYAI)United States$0.016B
BioCardia, Inc. (BCDA)United States$0.016B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
Jasper Therapeutics, Inc. (JSPR)United States$0.020B-0.37